Published in Am J Physiol Lung Cell Mol Physiol on August 05, 2011
Airway smooth muscle in airway reactivity and remodeling: what have we learned? Am J Physiol Lung Cell Mol Physiol (2013) 1.23
Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol (2014) 1.08
Perinatal nicotine-induced transgenerational asthma. Am J Physiol Lung Cell Mol Physiol (2013) 1.06
Maternal obesity, inflammation, and developmental programming. Biomed Res Int (2014) 0.94
Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol (2013) 0.86
Curcumin protects the developing lung against long-term hyperoxic injury. Am J Physiol Lung Cell Mol Physiol (2013) 0.85
Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS. Pediatr Res (2012) 0.81
On the evolution of development. Trends Dev Biol (2015) 0.81
Role of TGF-β signaling in curcumin-mediated inhibition of tumorigenicity of human lung cancer cells. J Cancer Res Clin Oncol (2012) 0.78
Transglutaminase 2: a new player in bronchopulmonary dysplasia? Eur Respir J (2014) 0.77
Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation. Am J Respir Cell Mol Biol (2016) 0.75
Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation. Front Physiol (2017) 0.75
Inhibition of adipogenesis by Wnt signaling. Science (2000) 9.72
Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med (1967) 9.56
Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A (1994) 6.46
Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics (2001) 5.58
Curcumin: the story so far. Eur J Cancer (2005) 4.17
Dose escalation of a curcuminoid formulation. BMC Complement Altern Med (2006) 3.59
The new BPD: an arrest of lung development. Pediatr Res (1999) 3.20
Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev (1995) 2.16
Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. Br J Nutr (2010) 1.96
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol (2009) 1.50
The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr Pathol Mol Med (2003) 1.49
The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu Rev Physiol (1997) 1.47
Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res (2007) 1.36
Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol (1997) 1.35
Role of adipocyte differentiation-related protein in surfactant phospholipid synthesis by type II cells. Am J Physiol Lung Cell Mol Physiol (2002) 1.32
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol (2006) 1.31
Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2006) 1.25
Development, repair and fibrosis: what is common and why it matters. Respirology (2009) 1.24
Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation. PPAR Res (2007) 1.19
Metabolism and fate of neutral lipids of fetal lung fibroblast origin. Biochim Biophys Acta (1995) 1.19
Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate (2000) 1.16
Hyperoxia augments pulmonary lipofibroblast-to-myofibroblast transdifferentiation. Cell Biochem Biophys (2003) 1.15
Biologic role of fetal lung fibroblast triglycerides as antioxidants. Pediatr Res (2001) 1.10
Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res (2009) 1.09
Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung (2008) 1.06
Pathogenesis of bronchopulmonary dysplasia. Respiration (2009) 1.03
Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 1.00
Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 0.99
Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology (2009) 0.99
1alpha,25(OH)2D3 and its 3-epimer promote rat lung alveolar epithelial-mesenchymal interactions and inhibit lipofibroblast apoptosis. Am J Physiol Lung Cell Mol Physiol (2009) 0.98
Lung evolution as a cipher for physiology. Physiol Genomics (2009) 0.94
Myofibroblasts in diffuse alveolar damage of the lung. Mod Pathol (1998) 0.93
Oxygen-induced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts. Mol Genet Metab (2002) 0.91
Preventive effects of curcumin and dexamethasone on lung transplantation-associated lung injury in rats. Crit Care Med (2008) 0.84
Inhibition of nicotine-induced toxicity by curcumin and curcumin analog: a comparative study. J Med Food (2004) 0.83
Expression of transforming growth factor beta (TGF-b1) by human preterm lung inflammatory cells. Life Sci (2006) 0.83
Techniques of early respiratory management of very low and extremely low birth weight infants. Neonatal Netw (2010) 0.79
[Effect of curcumin on the expression of collagen type I protein and transforming growth factor-beta1 mRNA in pulmonary fibrosis rats]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi (2008) 0.79
Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J Hypertens (2005) 1.72
Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med (2012) 1.51
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol (2009) 1.50
In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. Am J Physiol Lung Cell Mol Physiol (2007) 1.39
Evidence for the presence of lipofibroblasts in human lung. Exp Lung Res (2006) 1.38
Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res (2007) 1.36
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol (2006) 1.31
The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung (2009) 1.25
Thirdhand smoke causes DNA damage in human cells. Mutagenesis (2013) 1.14
PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung. PPAR Res (2012) 1.14
Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation. Am J Physiol Lung Cell Mol Physiol (2005) 1.12
Arrested pulmonary alveolar cytodifferentiation and defective surfactant synthesis in mice missing the gene for parathyroid hormone-related protein. Dev Dyn (2004) 1.11
Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res (2009) 1.09
Evidence for in vivo nicotine-induced alveolar interstitial fibroblast-to-myofibroblast transdifferentiation. Exp Lung Res (2010) 1.09
Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts. Exp Lung Res (2010) 1.08
Up-regulation of fetal rat lung parathyroid hormone-related protein gene regulatory network down-regulates the Sonic Hedgehog/Wnt/betacatenin gene regulatory network. Pediatr Res (2006) 1.07
Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung (2008) 1.06
Perinatal nicotine-induced transgenerational asthma. Am J Physiol Lung Cell Mol Physiol (2013) 1.06
1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab (2002) 1.04
Deconvoluting lung evolution using functional/comparative genomics. Am J Respir Cell Mol Biol (2004) 1.04
Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells. J Lipid Res (2008) 1.04
PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring. Am J Physiol Lung Cell Mol Physiol (2011) 1.00
Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 0.99
Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung. Am J Physiol Lung Cell Mol Physiol (2003) 0.99
Mechanism of reduced lung injury by high-frequency nasal ventilation in a preterm lamb model of neonatal chronic lung disease. Pediatr Res (2011) 0.98
In vitro effects of pirfenidone on cardiac fibroblasts: proliferation, myofibroblast differentiation, migration and cytokine secretion. PLoS One (2011) 0.96
Thirdhand smoke: a new dimension to the effects of cigarette smoke on the developing lung. Am J Physiol Lung Cell Mol Physiol (2011) 0.96
Leptin stimulates Xenopus lung development: evolution in a dish. Evol Dev (2009) 0.95
Effect of maternal food restriction on fetal rat lung lipid differentiation program. Pediatr Pulmonol (2009) 0.95
Evolutionary biology redux. Perspect Biol Med (2013) 0.95
Assessment of exhaled breath condensate pH. Am J Respir Crit Care Med (2011) 0.94
A paradoxical temporal response of the PTHrP/PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung. Am J Physiol Lung Cell Mol Physiol (2007) 0.93
Characterization of a novel fibroblast growth factor 10 (Fgf10) knock-in mouse line to target mesenchymal progenitors during embryonic development. PLoS One (2012) 0.92
Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression. Am J Obstet Gynecol (2008) 0.92
Effects of maternal food restriction on offspring lung extracellular matrix deposition and long term pulmonary function in an experimental rat model. Pediatr Pulmonol (2011) 0.91
A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-β1-mediated injury in the developing murine lung. BMC Cell Biol (2011) 0.91
Oxygen-induced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts. Mol Genet Metab (2002) 0.91
The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury. Antioxid Redox Signal (2014) 0.90
Sex-specific perinatal nicotine-induced asthma in rat offspring. Am J Respir Cell Mol Biol (2012) 0.90
Stem cell aging in the Drosophila ovary. Age (Dordr) (2005) 0.88
Lower parathyroid hormone-related protein content of tracheal aspirates in very low birth weight infants who develop bronchopulmonary dysplasia. Pediatr Res (2006) 0.87
Deconvoluting lung evolution: from phenotypes to gene regulatory networks. Integr Comp Biol (2007) 0.85
Exploiting the PTHrP signaling pathway to treat chronic lung disease. Drugs Today (Barc) (2007) 0.85
Role of adipose differentiation-related protein in lung surfactant production: a reassessment. J Lipid Res (2006) 0.85
Conditional switches for extracellular matrix patterning in Drosophila melanogaster. Genetics (2008) 0.83
Metyrapone blocks maternal food restriction-induced changes in female rat offspring lung development. Reprod Sci (2013) 0.83
Postnatal rosiglitazone administration to neonatal rat pups does not alter the young adult metabolic phenotype. Neonatology (2011) 0.83
Prenatal rosiglitazone administration to neonatal rat pups does not alter the adult metabolic phenotype. PPAR Res (2012) 0.82
Conditional inactivation of MRG15 gene function limits survival during larval and adult stages of Drosophila melanogaster. Exp Gerontol (2010) 0.81
Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men. Clin Ther (2011) 0.81
Two hundred eight patients with apical hypertrophic cardiomyopathy in china: clinical feature, prognosis, and comparison of pure and mixed forms. Clin Cardiol (2011) 0.81
[Impact of six genetic polymorphisms on Warfarin maintenance dose variation in Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2014) 0.79
Perfluorooctane sulfonate disturbs Nanog expression through miR-490-3p in mouse embryonic stem cells. PLoS One (2013) 0.78
The efficacy and safety of ivabradine hydrochloride versus atenolol in Chinese patients with chronic stable angina pectoris. Pharmacoepidemiol Drug Saf (2014) 0.78
Elevation of IGF-2 receptor and the possible underlying implications in end-stage heart failure patients before and after heart transplantation. J Cell Mol Med (2012) 0.78
[Establishment and preliminary validation of warfarin maintenance dose algorithm in Chinese Han Population]. Zhonghua Xin Xue Guan Bing Za Zhi (2014) 0.77
The Prevalence and Long-Term Outcomes of Extreme Right versus Extreme Left Ventricular Hypertrophic Cardiomyopathy. Cardiology (2015) 0.77
Comment on "Evo-Devo and the lungfish: the last gasp of intelligent design". FASEB J (2007) 0.76
Genetic anticipation in a special form of hypertrophic cardiomyopathy with sudden cardiac death in a family with 74 members across 5 generations. Medicine (Baltimore) (2017) 0.75
Forces in emphysema: Newtonian v quantum mechanics. Am J Respir Crit Care Med (2004) 0.75
Efficacy and Safety of 1-Hour Infusion of Recombinant Human Atrial Natriuretic Peptide in Patients With Acute Decompensated Heart Failure: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Medicine (Baltimore) (2016) 0.75
PPARs: Regulators and Translational Targets in the Lung. PPAR Res (2012) 0.75
"Failure to communicate" due to forgetting "marriage vow"? Am J Respir Crit Care Med (2004) 0.75
A new compass for activin research--a triumph for systems biology. Endocrinology (2011) 0.75
Determination of aranidipine and its active metabolite in human plasma by liquid chromatography/negative electrospray ionization tandem mass spectrometry. Rapid Commun Mass Spectrom (2006) 0.75
Association between red cell distribution width and myocardial infarction in rheumatoid arthritis. Clin Chem Lab Med (2015) 0.75
Sensitive method for the determination of ibutilide in human plasma by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 0.75
[Clinical features and long-term outcome comparison of patients with midventricular obstructive hypertrophic cardiomyopathy and apical hypertrophic cardiomyopathy]. Zhonghua Xin Xue Guan Bing Za Zhi (2015) 0.75
Randomized Trial to Compare Renal Function and Ductal Response between Indomethacin and Ibuprofen Treatment in Extremely Low Birth Weight Infants. Neonatology (2016) 0.75
Development and validation of a liquid chromatography-tandem mass spectrometric assay for pitavastatin and its lactone in human plasma and urine. J Chromatogr B Analyt Technol Biomed Life Sci (2008) 0.75
Sensitive quantification of ranolazine in human plasma by liquid chromatography--tandem mass spectrometry with positive electrospray ionization. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.75
Does NT-proBNP remain a sensitive biomarker for chronic heart failure after administration of a beta-blocker? Clin Cardiol (2007) 0.75
Development and validation of a sensitive LC-MS/MS-ESI method for the determination of ivabradine in human plasma: application to a pharmacokinetic study. Biomed Chromatogr (2013) 0.75